NEUROENDOCRINE CARCINOMAS
Clinical trials for NEUROENDOCRINE CARCINOMAS explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE CARCINOMAS trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE CARCINOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug targets Hard-to-Treat neuroendocrine cancers
Disease control Not yet recruitingThis trial tests an experimental drug called CTX-471 in people with advanced neuroendocrine tumors that have a specific marker (NCAM) and have stopped responding to standard treatments. Participants receive the drug by IV every two weeks. The study aims to see if the drug can shr…
Matched conditions: NEUROENDOCRINE CARCINOMAS
Phase: PHASE2 • Sponsor: Compass Therapeutics • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New study maps cancer treatment journeys across latin america
Knowledge-focused Not yet recruitingThis study looks back at medical records of 200 adults in Latin America with a rare and aggressive cancer called neuroendocrine carcinoma. Researchers want to understand how patients are diagnosed, what treatments they receive, and how their disease progresses over time. The goal…
Matched conditions: NEUROENDOCRINE CARCINOMAS
Sponsor: Latin American Cooperative Oncology Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC